Amiodarone and N-Acetylcysteine or Amiodarone Alone for Preventing Atrial Fibrillation After Thoracic Surgery

Running, not enrolling · Phase 3 · Has a placebo group

Conditions studied: Thoracic Surgery, Atrial Fibrillation in High Risk Patients

In brief

This trial will be comparing the combination of amiodarone and NAC (n=122) to amiodarone alone and NAC matched placebo (n=122) to determine the rates with which sustained (lasting \>30 seconds) or clinically significant POAF is reduced in high risk patients within 7 days after major thoracic surgery.

Key facts

Study ID
NCT02750319
Run by
Memorial Sloan Kettering Cancer Center
People needed
184
Starts
2016-04-01
Expected to finish
2027-04-01
Last updated by the study team
2026-05-19

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.